Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

Assessing flu's pandemic potential

November 20, 2006 | A version of this story appeared in Volume 84, Issue 47

H5N1's sugar preference may help health officials assess whether a given strain of the infamous avian influenza virus has the potential to start a human pandemic. A group of 23 international researchers led by Yoshihiro Kawaoka of both the University of Tokyo and the University of Wisconsin, Madison, pinpointed mutations in an H5N1 protein that switch the virus's ability to infect avian or human hosts (Nature 2006, 444, 378). This change of appetite occurs in a viral protein called hemagglutinin, whose binding to sugars located on bird or human host receptor proteins leads to infection. Avian H5N1 hemagglutinin has a predilection for bird protein receptors laced with sialic acid-α2,3-galactose. Human H5N1 hemagglutinin prefers sialic acid-α2,6-galactose, common to human receptor proteins. The researchers identified several amino acids in the hemagglutinin's binding cleft that help switch a virus that goes after birds to one that targets humans. Those residues could be useful when assessing the pandemic potential of H5N1 samples.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.